Bellerophon Therapeutics, Inc. 4
4 · Bellerophon Therapeutics, Inc. · Filed Apr 29, 2016
Insider Transaction Report
Form 4
Luehring Jens
Director10% Owner
Transactions
- Award
Common Stock
2016-04-28+19,860→ 19,860 total
Holdings
- 1,629,804(indirect: See footnote)
Common Stock
Footnotes (1)
- [F1]These shares are owned directly by Linde North America, Inc. ("Linde"). Jens Luehring is a director and chief financial officer of Linde. Mr. Luehring disclaims beneficial ownership of all shares held by Linde, except to the extent of his pecuniary interest therein.